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Abstract
Structurally diverse synthetic insecticides and acaricides had been shown to inhibit the proton-translocating
 .NADH:ubiquinone oxidoreductase complex I activity. In addition, secondary metabolites from microbial and plant sources
known to act on complex I exhibited biological activity against agricultural and environmental insect pests. Mechanistic
 .studies indicated that these compounds interfered with ubiquinone reduction most likely at the same site s as the classical
complex I inhibitors rotenone and piericidin A. Two approaches to characterize the mechanism of insecticidalracaricidal
complex I inhibitors were followed: enzyme kinetic studies and binding studies with radiolabeled inhibitors. Enzyme kinetic
experiments were sometimes controversially interpreted regarding a competitive or non-competitive inhibitor mechanism
with respect to the electron acceptor. In general, radioligand binding data with submitochondrial membranes were in line
with the enzymological results but due to methodological drawbacks, saturation kinetic analyses were impossible. The main
 .problems underlying many studies of inhibitor interaction with complex I were i the use of membrane-bound enzyme
 .preparations and ii the physicochemical properties of the amphiphilic inhibitors with their strong tendency to accumulate
in the membrane phase. A more recent approach to characterize inhbibitor interaction sites in complex I was the isolation of
piericidin-resistant mutants of photosynthetic bacteria which produce a simpler homologue of mitochondrial NADH:Q
oxidoreductase. q 1998 Elsevier Science B.V.
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1. Introduction
Following the United Nations’ Food and Agricul-
 .ture Organization FAO , global human population
will increase to about 7.2 billion by 2010 with an
w xannual growth rate of 1.7% 1 . This population
increment has to be accompanied by a substantial
enhancement in food supply by a more productive
agriculture at the global level.
) Fax: q49-69-305-17207; E-mail:
peter.luemmen@agrevo.com
1 Dedicated to the memory of Dr. Gerhard Salbeck.
Chemical insecticides, together with genetically
modified insect-resistant crops and biological plant
protection methods, prevent severe harvest losses due
to phytophageous insects and mites.
 .A few important in terms of market size chemi-
cal insecticide classes show a broad spectrum of
biological activity and have thus been used for years
in agricultural applications. They are mainly neuro-
toxins directed against a limited range of receptors
and enzymes: acetylcholinesterase organophosphates,
.carbamates , the voltage-dependent sodium channel
 .DDT, pyrethroids, dihydropyrazoles , the GABA re-
ceptorrchloride channel cyclodienes, phenylpyra-
0005-2728r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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. w xzoles 2,3 , and the nicotinic acetylcholine receptor
 . w xnitromethylenes 4 .
Resistances arising in insect field populations
against almost all classes of chemical insecticides had
been reported. Since target site insensitivity was iden-
tified as one of the predominant resistance mecha-
w xnisms 5 , the major objective for insecticide research
is the identification of new chemical classes with new
molecular modes of action.
During the last years, new insecticidesracaricides
were developed interfering with mitochondrial elec-
tron transport, most of them with the proton-trans-
locating NADH:ubiquinone oxidoreductase complex
. w xI 6–8 . It is worth mentioning that complex I is not
a completely new insecticide target since one of the
classical complex I inhibitors, rotenone, is known for
 .its weak and limited insecticidal activity.
Present knowledge of complex I is primarily based
on studies with bovine heart and Neurospora crassa
enzymes, whereas little is known about the structures
of insect NADH:ubiquinone oxidoreductases. It is
noteworthy that insect flight muscles represent a rich
w xsource of electron transport enzyme activities 9 .
Enzymatic and immunochemical evidence indicated a
high degree of similarity to their mammalian and
w xfungal counterparts 10 .
Proton-translocating NADH:ubiquinone oxido-
reductase is the first electron transport complex of the
mitochondrial respiratory chain. It oxidizes NADH
and transfers the electrons via a flavin mononu-
cleotide cofactor and several iron–sulfur clusters to
 .ubiquinone Q . A 4 protons per 2 electrons stoi-
chiometry is the widely accepted figure for the cou-
pled vectorial proton translocation. So, complex I
contributes to the proton-motive force that drives
ATP synthesis. Presumably because of its high de-
gree of structural complexity, NADH:Q oxidoreduc-
tase is the least understood of the respiratory chain
w xenzymes 11 .
A detailed discussion of structure and function of
complex I is far beyond the scope of this review.
Only selected structural aspects of immediate impor-
tance for the discussion of inhibitor mechanisms will
be outlined here briefly. For a more comprehensive
w xview, the reader is referred to recent reviews 12–15
and to the relevant contributions in this volume.
Complex I of bovine heart mitochondria consists
of more than 40 subunits with a total molecular mass
Fig. 1. Schematic diagram of complex I illustrating the molecular
mode of action of selected insecticidesracaricides. Only the
w xsequence of electron transfer reactions 11,13,14 is schematically
depicted, leaving out the proton-translocation step. From the
point of view of inhibitor mechanism, iron sulfur cluster N2 is
most interesting because it has the highest midpoint potential
w x14,15 and is therefore the likely candidate for ubiquinone
w xreduction 12,15 . In addition, N2 may be in direct contact with
w xthe membrane arm 12 . Considering the lack of precise structural
and mechanic knowledge, it is presently sufficient to point out
that the pyrazole and aminopyrimidine insecticides block electron
transfer between cluster N2 and Q.
w xof about 900 kDa 15 . With the non-ionic detergent
 .N, N-dimethyldodecylamine N-oxide LDAO , bovine
w xcomplex I is splitted into different subcomplexes 16 .
Subcomplex Il roughly corresponds to the peripheral
 . w xarm of the L-shaped N. crassa enzyme Fig. 1 17 .
It carries the FMN cofactor and all EPR–visible
iron–sulfur clusters and catalyzes NADH oxidation
with the isoprenoid Q analogue Q-1 as electron ac-
 .ceptor. Rotenone-sensitive ubiquinone Q reduction
requires the hydrophobic integral membrane part of
complex I presumably containing the physiological
 .ubiquinone reduction site s . These are believed to be
relatively hydrophobic but access to the aqueous
phase is necessary for proton uptake in the course of
w xQ reduction 18 . However, this picture remains to be
confirmed by structural data.
The mechanistic linkage between redox reactions
and proton-translocation is still a matter of debate,
but it has immediate relevance for the number of
Qrinhibitor binding sites and the mechanism how
inhibitors interfere with energy conservation. Differ-
ent models have been proposed in the literature, for a
w xrecent synopsis see the review of Brandt 19 .
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This review will summarize the present knowledge
about the biochemical mechanisms of selected syn-
thetic and natural complex I inhibitors from different
chemical families showing insecticidal andror acari-
cidal activity.
2. Insecticides and acaricides as inhibitors of com-
plex I
Rotenone and piericidin A were known for a long
time as high-affinity inhibitors of proton-translocat-
ing NADH:Q oxidoreductase. Piericidin A was iso-
w xlated from cultures of Streptomyces mobaraensis 20
and rotenone was the active component in the insecti-
cidal and fish-poisonous extract of Derris spec.
 .Leguminosae roots.
During the last years, new potent insecticides
racaricides were shown to inhibit mitochondrial res-
piration at coupling site I. Further enzymatic analysis
indicated that they specifically blocked ubiquinone-
dependent NADH oxidation with high efficacy.
The synthetic insecticidesracaricides could be
grouped in two main classes, the pyrazoles in the first
class and substituted pyrimidines, pyridines and
quinazolines in the second class. Experimental and
 .  .Fig. 2. Structures of insecticidesracaricides active on complex I. Synthetic compounds: A fenpyroximate NNNI-850, Nihon Nohyaku ;
 .  .  .  .  .  .  .B tebufenpyrad MK-239, Mitsubishi Kasei ; C fenazaquin EL-436, DowElanco ; D SAN 548A Sandoz, now Novartis ; E
 .  .  .  .  .pyrimidifen SU-8801, Ube Industries ; F Hoe 110779 Hoechst, now AgrEvo ; G pyridaben NC-129, Nissan Chem. . Secondary
 .  .  .metabolites: H thiangazole; I annonin VI annonaceous acetogenin .
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commercial insecticides representing the two syn-
thetic classes as well as natural compounds with
insecticidal activity will be presented in the follow-
ing.
2.1. Pyrazoles
Members of the substituted pyrazole family were
discovered as effective acaricides and introduced to
the market by Japanese companies.
 .Fenpyroximate NNI-850, Fig. 2A was a 5-pheno-
xypyrazole commercialized by Nihon Nohyaku in
1991. After spraying with fenpyroximate, oxygen
consumption and the total ATP content of adult
spider mites Tetranychus urticae were drastically
w xdecreased 21 . Further biochemical analysis revealed
that NADH:Q oxidoreductase activities in rat liver
and Tetranychus mitochondrial membranes were in-
hibited with IC values of 0.4 and 0.08 mM, respec-50
tively. NADH:ferricyanide reductase was not affected
by inhibitor concentrations up to 10 mM. Interest-
ingly, electron microscopy revealed morphological
changes of mitochondria isolated from different tis-
sues indicating that the peripheral nerve cells ap-
peared to be most sensitive to fenpyroximate. This
might explain the characteristic intoxication sympto-
mology like rapid knockdown and paralysis.
The related pyrazole-5-carboxamide acaricide
 .tebufenpyrad MK-239, Fig. 2B from Mitsubishi
Kasei controlled different spider mite species and
also some sucking insects. Complex I was identified
w xas the molecular target 7 .
MK-239 inhibited NADH:decylubiquinone oxido-
reductase activity in housefly flight muscle submito-
chondrial membranes with an IC of 2.0 nM50
 .Lummen, unpublished .¨
2.2. Pyridines, pyrimidines and quinazolines
This familiy contains N-heterocyclic compounds
like pyridine, pyrimidine or quinazoline with a
lipophilic side chain attached to them via a bridging
atom.
 .Fenazaquin EL-436, Fig. 2C was discovered by
DowElanco as an acaricide with good efficacy against
motile forms and eggs of spider mites. Hollingworth
w xet al. 8 showed that complex I inhibition was the
molecular mode of action.
The experimental aminoquinazoline insecticide
 .SAN 548A Fig. 2D inhibited bovine heart
NADH:Q-1 oxidoreductase, but NADH:ferricyanide
w xactivity was not affected 8 .
Substituted aminopyrimidines, including the
SankyorUbe developmental product pyrimidifen
 .Fig. 2E , and the similar Hoe 110779 of
 .HoechstrAgrEvo Fig. 2F were effective insecti-
cides and acaricides against a broad pest spectrum
including aphids, lepidoptera, coleoptera and bugs
w x21 . Hoe 110779 completely blocked rotenone-sensi-
tive, n-decylubiquinone-dependent NADH oxidation
by membrane-bound complex I from a variety of
biological sources like rat heart, housefly flight mus-
cles, N. crassa, and the bacterium Paracoccus deni-
 w x .trificans Ref. 22 and Lummen, unpublished . On¨
the contrary, NADH:ferricyanide oxidoreductase and
the Escherichia coli NDH2-type NADH:Q oxido-
 .reductase non proton-translocating were not in-
hibitied.
2.3. Pyridaben
 .The pyridazinone compound pyridaben Fig. 2G
was introduced as an acaricide by Nissan Chemical .
Complex I was inhibited in mitochondrial prepara-
w xtions from different insect species 7 .
2.4. Annonaceous acetogenins
Plants from the family Annonaceae were known
to contain potent bioactive secondary metabolites
called annonins or acetogenins see for example an-
. w xnonin VI: Fig. 2I 23–25 . Biological activities in-
cluding pronounced insecticidal and antiparasitic ef-
fects had been described. Acetogenins were active
 . against aphids Aphis fabae , flies Calliphora ˝ic-
.  .ina , the Mexican bean beetle Epilachna ˝ari˝estis
 .and the diamondback moth Plutella xylostella .
The Annona squamosa annonins inhibited the
NADH-, but not succinate-dependent cytochrome c
reduction in submitochondrial particles from blowfly
w xflight muscles 24 . Asimicin, an insecticidal aceto-
genin from Asimina triloba, blocked oxygen con-
sumption in larval European corn borer mitochondria
w xtypical of a coupling-site I inhibitor 23 . Bullatacin,
selected from a metabolite screening program of over
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50 species of Annonaceae, affected cellular respira-
tion in cultured Spodoptera frugiperda Sf9 cells and
in mitochondrial preparations from the tobacco horn-
 .worm Manduca sexta measured with the Clark-type
w xoxygen electrode 25 .
2.5. Thiangazole
 .Thiangazole Fig. 2H was isolated from a
Polyangium strain. Insecticidal, acaricidal and an-
thelmintic activity were claimed in a patent applica-
w xtion 26 . Complex I inhibition was shown by
w xFriedrich et al. 27 .
2.6. Structure-acti˝ity relationships
A common structural feature could be seen in the
N-heterocyclic ring substituted with a lipophilic side
chain via a bridging nitrogen or oxygen atom. Little
information had been published on structure-activity
relationships with respect to the synthetic complex
I-active insecticides. For the pyrazole carboxamide
 .series Fig. 2B , biological activity against spider
mites was correlated with the chemical variations of
w xthe lead structure 28 . Certain substituent positions
of the pyrazole ring including lower alkyl and halo-
gen were essential for biological activity. In the
lipophilic side chain, higher degrees of freedom were
possible when the 4-alkyl substituent of the benzylic
moiety was altered.
w xObata et al. 29 systematically analyzed chemical
variations in the aminopyrimidine series with respect
to their biological activity. The most potent com-
pounds were substituted by lower alkyl or halogen in
the 5- and 6-positions of the pyrimidine ring. When
lower alkyl substituents were introduced at the 1-
position of the lipophilic side chain, an asymmetric
 .carbon center was created. The q optical isomer
 .was found to be more potent than the y isomer. As
in the case of the pyrazoles, broad chemical varia-
tions including alkyl and diphenylether moieties were
possible in the lipophilic side chain.
Although the presented structure-activity relations
were not based on enzymatic measurements, it is
reasonable to assume that the most active insecticides
were also effective complex I inhibitors. By compari-
son with related compounds like 4-hydroxypyridines,
w x4-hydroxyquinolines 30 and 2-alkyl-3-methyl-
w xquinolones 31 , one could speculate about common
structural determinants of inhibitor activity. For the
piericidin-type 4-hydroxypyridines and 4-hydroxy-
quinolines, a p-electron interaction between the het-
eroaromatic ring and the binding site was suggested.
The lipophilic side chain length played a role for
w xinhibitor efficacy 30 . This was also true for the
2-alkylquinolones, where 9–12 carbon atoms in the
w xn-alkyl chain gave maximum activity in vitro 31 .
In summary, structure-activity relationships of the
insecticidal N-heterocycles were largely speculative.
Assuming that some thousands of compounds had
been synthesized by different companies, this would
form a good basis to systematically elaborate the
structural determinants for complex I inhibition.
3. Molecular mechanism of complex I inhibition
In enzymatic assays with membrane-bound or sol-
ubilized NADH:Q oxidoreductase, the complex I-ac-
tive insecticides closely resembled the classical in-
hibitors rotenone and piericidin which block electron
transport between iron–sulfur cluster N2 and
w xubiquinone 6,8,22,27 . Recently, proposed models to
explain the redox mechanism of complex I with its
 .associated proton-pump implied two or even three
Q binding sites. It was proposed that inhibitors from
the structurally diverse chemical classes might specif-
ically interact with different Q sites, thus providing
the experimental tools to test the corresponding model
w x19,32,33 . Consequently, efforts have been made to
define the number of Q sites by studying complex I
inhibitor mechanisms and binding site specificity.
In the following, mechanistic analyses of complex
I inhibitors, with emphasis on the insecticidally active
compounds, are discussed in the context of complex I
structure and function. The majority of information
comes from enzyme kinetic studies mostly with
 .membrane bound, but also solubilized and partially
purified complex I.
Radioligand binding experiments represent a
straightforward method to describe ligand–protein
interactions directly: applications of these methods to
the study of inhibitor binding to complex I are pre-
sented.
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A start has been made to apply the powerful tools
of molecular genetics on complex I inhibitor binding
site analysis by characterizing inhibitor-resistant mu-
tants of the bacterial proton-translocating NADH:Q
oxidoreductase.
3.1. Enzyme kinetic studies
w xFriedrich et al. 34 characterized 12 structurally
diverse inhibitors 10 natural, two synthetic com-
.pounds in terms of Michaelis–Menten-type inhibi-
tion kinetics with membrane-bound and reconstituted
NADH:Q oxidoreductase from N. crassa. They de-
fined two inhibitor classes. The pyrazole acaricide
fenpyroximate blocked ubiquinone-2 reduction in a
partially competitive manner similar to piericidin A
 .and annonin VI class I . Class II inhibitors, repre-
sented for example by rotenone, exhibited non-com-
petitive behaviour under the same experimental con-
ditions.
In agreement with these results, Hollingworth et
w xal. 8 reported that two other members of the quina-
zolinerpyrimidine family, fenazaquin and SAN
548A, were competitive inhibitors of NADH:Q-1 ac-
tivity in bovine heart mitochondrial membranes and
purified complex I preparations. Mutually exclusive
binding of rotenone and the quinazolinerpyrimidine
insecticides was postulated.
According to the criteria of Friedrich et al., the
aminopyrimidine insecticide Hoe 110779 competi-
tively inhibited membrane-bound complex I from
housefly mitochondria measured with n-decyl-
w xubiquinone 22 .
Jewess tested a number of structurally not explic-
itly specified lipophilic insecticidesracaricides in-
cluding examples from the pyrazole and the quinazo-
w xlinerpyrimidine families 35 . Facing the problem of
unstable solubilized insect complex I he used sub-
mitochondrial particles from blowfly Lucilia cae-
.sar flight muscles to measure Q-1-dependent NADH
oxidation. Inhibition kinetics of all compounds tested
showed largely non-competitive behaviour with re-
spect to Q-1 and non-competitive behaviour with
NADH.
The molecular mode of action of the insecticidal
acetogenins had been studied by several groups. Lon-
w xdershausen et al. 24 suggested that annonins,
rotenone and piericidin shared a common binding
site. Inhibition of complex I by acetogenins was
w xconfirmed by Ahammadsahib et al. 25 for bullat-
w xacin. Degli Esposti et al. 36 analysed in depth the
inhibitor mechanism of rolliniastatins against 6-unde-
cyl-Q reductase. Rolliniastatin-1 and rolliniastatin-2
 .possibly identical to bullatacin were found to be the
most effective complex I inhibitors so far with Ki
values of 0.3 and 0.6 nM, respectively.
w xContrary to Friedrich et al. 34 , who identified
annonin VI to be a competitive inhibitor of Q-1
w xreduction, Degli Esposti et al. 36 described rollinias-
tatin inhibition to be uncompetitive, i.e., the slope of
double-reciprocal data transformations was not
changed between inhibited and control activities. All
rolliniastatins were mutually exclusive with piericidin
and rotenone under steady-state conditions except for
rolliniastatin-2, which did not interfere with rotenone
binding. Consequently, an independent binding site
for rolliniastatin-2 not overlapping the rotenone site
was postulated.
So far, enzyme kinetics did not provide a clear
picture regarding the inhibitory mechanisms and the
number of inhibitor binding sites. The sometimes
confusing, sometimes even contradictory results could
be explained at least partially by the heterogeneous
enzymatic assay conditions. Most remarkable was the
 .discrepancy between the partially competitive be-
haviour of the pyrimidinerquinazoline insecticides
w x w xagainst Neurospora 27,34 and bovine 8 membrane
w xbound complex I and Jewess’s 35 data stating non-
 .competitive inhibition of the insect L. caesar en-
zyme. A functional uniqueness of the insect complex
I in this respect is rather unlikely since housefly
complex I activity, tested with submitochondrial
membranes with n-decylubiquinone, was also com-
w xpetitively inhibited 22 . Possibly, the different Q
analogues, Q-1 and decyl-Q, used in the activity
assays could provide an explanation. Subtle differ-
ences between Q analogues in supporting the
energy-conserving function of complex I were identi-
w xfied by Degli Esposti et al. 33 . The authors recom-
mended decyl- or undecyl-Q which most closely
resembled the functions of endogeneous ubiquinone.
w xFinel et al. 16 observed that all the subcomplexes
generated by differential solubilization with LDAO
and lauroylsarcosine retained NADH-oxidation activ-
ity with Q-1 irrespective of their inhibitor sensitivity.
However, rotenone sensitivity was correlated with
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n-decylubiquinone-dependent NADH-oxidation indi-
cating different Q reduction sites with particular in-
hibitor specificities in solubilized complex I.
Clearly, conclusions concerning the inhibitor
mechanisms and the number of binding sites of mem-
brane-bound N. crassa complex I presented by
w xFriedrich et al. 34 were based on a Michaelis–
Menten relationship between initial velocity and the
Q-2 concentration. In contrast, membrane-bound
complex I activity in L. caesar flight muscles as a
function of Q-1 or Q-2 electron acceptor concentra-
w xtions deviated from Michaelis–Menten kinetics 35 .
Heterogeneous and possibly co-operative Q binding
sites were derived from the sigmoidal curves.
Inhibition of the Gluconobacter oxidans glucose
dehydrogenase was proposed as a second distinctive
w xcriterium between class I and II compounds 34 . The
bacterial inner-membrane enzyme catalyzes the direct
oxidation of extracellular glucose to gluconate em-
 .ploying a pyrroloquinoline quinone PQQ redox co-
factor. Two electrons are transferred to ubiquinone
linking periplasmic glucose oxidation to the respira-
w xtory electron transport chain 37 . Fenpyroximate in-
hibited glucose dehydrogenase-catalyzed Q reduction
at higher concentrations, but class II inhibitors showed
w xweak, if any, inhibition 34 .
The ND1 subunit of complex I had been suggested
to contribute at least in part to the binding site for
rotenone. This was concluded from photoaffinity la-
w3 x w xbeling experiments with H dihydrorotenone 38 .
By sequence alignment with bacterial glucose dehy-
w xdrogenase, Friedrich et al. 39 postulated a common
sequence motif for ubiquinone binding. The rele-
w xvance of this homology had been questioned 15 .
Nevertheless, the specificity of Q-site inhibitors for
different Q-dependent oxidoreductases may still pro-
vide valuable information on general structural and
physicochemical features of quinonerinhibitor bind-
w xing sites 18 . It is noteworthy in this context that
high-affinity bc complex inhibitors like stigmatellin1
and myxothiazol also block NADH:ubiquinone
oxidoreductase at higher concentrations supporting
the hypothesis of common structural features for Q
w xsite inhibition 40 .
In summary, enzyme kinetics provided useful in-
formation on insecticideracaricide molecular mode
of action but the kinetics of complex I activity will
have to be defined more precisely to understand the
structural and mechanistic determinants of complex I
inhibitors.
The particular physicochemical properties of com-
plex I inhibitors should also be considered. The
strong tendency of hydrophobic or, more precisely,
amphiphilic inhibitors to accumulate in the small
membrane volume in comparison with the aqueous
phase under assay conditions substantially increases
the actual inhibitor concentration at the target site.
So, the apparent IC and K values do not only50 i
reflect the specific interaction between the inhibitor
and its binding site, but to a significant extent, the
entropy-driven, hydrophobic interaction with the
membrane. So, comparisons of relative inhibitory
efficacies have to be interpreted very carefully.
Solubilized and purified complex I preparations of
maximum structural and functional integrity would
resolve most of the uncertainties described above.
Substantial progress has been made during the last
years in obtaining purified complex I enzymes or
their bacterial homologues for structural analyses
w x41–44 . Some of these enzyme preparations retained
their inhibitor sensitivity and should be useful for
enzyme kinetic studies.
3.2. Radioligand binding methods
In principle, radioligand binding experiments pro-
vide a direct method to quantitatively describe lig-
w xand-receptor interactions. Jewess 35 and Wood et
w xal. 45 adopted this approach to study the binding
site specificity of selected complex I-active insecti-
cides with submitochondrial membranes from the
blowfly L. caesar and bovine heart, respectively.
Piericidin, the pyrazole acaricide fenpyroximate
 .and other not structurally specified insecticides in-
w3 xhibited specific H dihydrorotenone binding in a
concentration-dependent fashion with IC values50
w xranging from 30 to 100 nM 35 . The results were
interpreted in favour of a direct competition between
 .the insecticidal inhibitors and also piericidin at the
same, or very close to, the binding site of dihydro-
rotenone. A more convincing conclusion would have
required to show, for example by Scatchard analysis,
that the maximum number of binding sites B wasmax
not altered when dihydrorotenone plus a competing
ligand were present under steady state conditions.
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In fact, saturation binding analysis was not possi-
ble, most likely prevented by the strong non-specific
binding of the hydrophobic radioligand to the mem-
brane phase.
Testing diverse Q analogues revealed weak, if any,
dihydrorotenone displacement: the IC of Q-2 was50
determined 400 mM and the n-decyl-Q analogue was
completely inactive. From these results, separate
binding sites for Q and the inhibitors were postulated,
apparently confirming the non-competitive enzyme
w xinhibition kinetics 35 . The possibility that quinone
concentrations tested were not sufficient to displace
w3 xthe high-affinity radioligand H dihydrorotenone
 .K s29 nM; Lummen, unpublished could not be¨D
ruled out. It is known that quinones have weak
binding constants allowing rapid movement on and
 . w xoff the binding site s 18 . So, significant displace-
ment of a tight-binding ligand would necessarily
require high quinone concentrations under steady state
conditions. Performing the binding analyses with a
radioligand of lower affinity could help to clarify the
binding site specificity with respect to Q.
w xWood et al. 45 studied the effect of rotenone, the
quinazoline insecticide SAN 548A, the acaricide
pyridaben, and the acetogenins asimicin and bullat-
w3 xacin on H fenazaquin binding in equilibrium bind-
ing experiments with bovine heart submitochondrial
particles. Due to the high percentage of non-specific
 .radioligand binding 58% , meaningful saturation ki-
netic analyses were not possible. Incorporation of
BSA in the binding assays did not improve specific
binding.
Selected insecticidalracaricidal complex I in-
hibitors were tested for their ability to reduce specific
fenazaquin binding. The acaricide pyridaden and the
acetogenins asimicin and bullatacin inhibited 85% of
fenazaquin binding at 30 nM. Rotenone and the
quinazoline insecticide SAN 548A were less potent,
showing 59% and 67% inhibition, respectively. A
 2 .good correlation r s0.96, ns18 was found be-
tween inhibition of NADH:ubiquinone oxidoreduc-
tase and fenazaqin binding. The authors pointed out
correctly, that it was not clear if all compounds
competed for the same binding site or alternatively
blocked fenazaquin binding in a non-competitive
w xmanner 45 .
As discussed above in the context of enzyme
kinetic studies, the use of submitochondrial mem-
branes presented methodological problems in the
analysis of hydrophobic ligand interaction with com-
plex I. A solubilzed and purified enzyme preparation
could presumably be suitable for Scatchard analysis
of saturation binding data. If a competing inhibitor
did not change the apparent B of the radioligand,max
a common, or at least overlapping, binding site could
be postulated.
3.3. Inhibitor-resistant mutants
Genetic evidence for two inhibitor binding sites
w xwas presented by Darrouzet and Dupuis 46 . They
isolated piericidin-resistant mutants from the photo-
synthetic bacterium Rhodobacter capsulatus. The ap-
parent K values for piericidin measured with thei
bacterial complex I homologue, NADH dehydroge-
nase NDH-1, were increased by a factor of about 30
in two mutants compared to the wild-type control.
Cross-resistance to rotenone was found, but the sensi-
tivity to rolliniastatin-2 was not altered. Assuming
that bacterial NDH-1 enzymes resemble mitochon-
drial complex I with respect to inhibitor mechanisms
and binding sites, the characterization of resistance
mutants could lead to the identification of enzyme
subunits and the amino acid residues contributing to
inhibitor binding.
4. Conclusions
Proton-translocating NADH:Q oxidoreductase was
found to be the molecular target of new and struc-
turally diverse insecticides of synthetic and natural
origin. Convincing data in the literature on mem-
brane-bound and purified complex I from different
biological sources show that these compounds block
ubiquinone reduction similar to the classical in-
hibitors piericidin and rotenone.
With respect to the inhibitor mechanisms some
methodological problems remain to be solved. Using
purified complex I preparations for systematic en-
zyme kinetic and radioligand binding studies would
most probably resolve most of the ambiguities stated
above.
Concerning the number of quinone and inhibitor
binding sites, the picture is still far from being consis-
tent. A large Qrinhibitor binding domain in which
bound ubiquinones can easily exchange with the mo-
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bile Q pool in the membrane would fit to the pub-
lished data and could be a sensible working hypothe-
sis for the study of inhibitor specificity. The binding
domain should accomodate structurally heteroge-
neous inhibitor molecules which interact at overlap-
 .ping competitive, mutually exclusive , or at non-
overlapping non-competitive, mutually non-exclu-
.sive binding sites, defined by particular amino acid
residues in the binding domain. Clearly, at least part
of the inhibitor binding is governed by hydrophobic
interactions.
From the point of view of applied biochemistry,
extended structural and mechanistic knowledge of
complex I would help in the identification of new
efficient inhibitors for agrochemical application. On
the other hand, synthetic compounds of great struc-
tural variability will be valuable tools in basic re-
search to adress the intriguing questions of complex I
structure and reaction mechanism.
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